Gait disturbance interpreted as cerebellar ataxia after MMR vaccination at 15 months of age: A follow-up study

Acta Paediatrica, International Journal of Paediatrics

Volumn 89, Issue 1, 2000, Pages 58-63

  Plesner, A M ^a,b   Juul Hansen, F ^c   Taudorf, K ^c   Holme Nielsen, L ^c   Brenner Larsen, C ^c   Pedersen, E ^c  

^a STATENS SERUM INSTITUT   (Denmark)

^b Sundhedsstyrelsen   (Denmark)

^c NONE

Author keywords

Adverse reactions; Cerebellar ataxia; Gait disturbance; MMR vaccination

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; AUDIOLOGY; CEREBELLAR ATAXIA; CLINICAL ARTICLE; DRUG INDUCED DISEASE; DRUG SAFETY; FOLLOW UP; GAIT; HEALTH PROGRAM; HUMAN; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033958109     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2000.tb01188.x     Document Type: Article

References (26)

1. 1. Jonsell R, Romanus V, Böttiger M, Sandzelius G. BVC: god anslutning redan under första året. Läkartidningen 1984; 81: 1632-7
2. 2. Taranger J, Wiholm B-E. Litet antal biverkninger rapporterade efter vaccination mot mässling-påssjuka-röda hund. Läkartidningen 1987; 84: 948-50
3. 3. Fescharek R. Quast U, Maass G, Merkle W, Schwarz S. Measles -mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects. Vaccine 1990; 8: 446-56
4. 4. Plesner A-M. Gait disturbances after measles, mumps, and rubella vaccine. Lancet 1995; 345: 316
5. 5. Hansen KG. Vaccination against Haemophilus influenzae type b (Hib) in the Danish childhood vaccination programme [PhD thesis]. University of Copenhagen, 1997
6. 6. Plesner A. Measles, mumps and rubella vaccination (MMR) [PhD thesis]. University of Copenhagen, 1998
7. 7. Cutts F. Revaccination against measles and rubella. Br Med J 1996; 312: 589-90
8. 8. da Silveria CM, Salisbury DM, de Quadros CA. Measles vaccination and Guillain-Barré syndrome. Lancet 1997; 349: 14-6
9. 9. Miller D, Wadsworth J, Diamond J, Ross E. Measles vaccination and neurological events. Lancet 1997; 349: 730-1
10. 10. Swaiman KF. Gait impairment. In: Swaiman KF, editor Pediatric neurology. London: Mosby, 1994: 235-41
11. 11. Trump RC, White TR. Cerebellar ataxia presumed due to live, attenuated measles virus vaccine. JAMA 1967; 199: 165-6
12. 12. Landrigan PJ, Witte JJ. Neurologic disorders following live measles - virus vaccination. JAMA 1973; 223: 1459-62
13. 13. Koskiniemi M, Donner M, Pettay O. Clinical appearance and outcome in mumps encephalitis in children. Acta Pædiatr Scand 1983; 72: 603-9
14. 14. Miller HG, Stanton JB, Gibbons JL. Para-infectious encephalo-myelitis and related syndromes. Q J Med 1956; 100: 427-505
15. 15. Cohen HA, Ashkenazi A, Nussinovitch M, Amir J, Hart J, Frydman M. Mumps-associated acute cerebellar ataxia. Am J Dis Child 1992; 146: 930-1
16. 16. Dahlerup B. Morbilli-encephalitis. Ugeskr Lærger 1980; 142: 2616-8
17. 17. Tidstrøm B. Complications in measles with special reference to encephalitis. Acta Med Scand 1968; 184: 411-5
18. 18. Weis S, Guberman A. Acute cerebellar ataxia in infectious disease. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Amsterdam: North Holland Publishing Company, 1978: 619-39
19. 19. Krugman S, Ward R. Measles. In: Krugman S, Ward R, editors. Infectious diseases of children and adults. Saint Louis: Mosby, 1973: 106-22
20. 20. Gruenberg EM, Lewis C, Goldston SE, editors.. Vaccinating against brain syndromes: the campaign against measles and rubella. Monographs in epidemiology and biostatistics, vol. 9. New York: Oxford University Press, 1986
21. 21. Miller DL. Frequency of complications of measles, 1963. Br Med J 1964; 2: 75-8
22. 22. Modlin JF, Jabbour JT, Witte JJ, Halsey NA. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics 1977; 59: 505-12
23. 23. Gillberg C, Gillberg C, Groth J. Children with preschool minor neurodevelopmental disorders. V. Neurodevelopmental profiles at age 13. Develop Med Child Neurol 1989; 31: 14-24
24. 24. Miller E, Goldacre M, Pugh S, Colville A, Farrington P, Flower A, et al. Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children. Lancet 1993; 341: 979-82
25. 25. Odissev H, Gacheva N. Vaccine prophylaxis of mumps using mumps vaccine, strain Sofia 6, in Bulgaria. Vaccine 1994; 12: 1251-5
26. 26. Black S, Shinefiels H, Ray P, Lewis E, Chen R, Classer J, et aland the vaccine safety datalink group. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one-to two-year-old children: an analysis of the vaccine safety datalink (VSD) project. Pediatr Infect Dis J 1997; 16: 500-3